Tonix Pharmaceuticals Holding Corp Earnings

The next earnings date for Tonix Pharmaceuticals Holding Corp is November 10, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Tonix Pharmaceuticals Holding Corp Earnings

Report Date	Estimated Earnings Per Share
11/10/2025	$-3.22

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tonix Pharmaceuticals Holding Corp Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/11/2025	---	$-4.00	41.44%
05/22/2025	After Market	$-2.64	14.50%
03/31/2025	Before Market	$-9.77	---
11/07/2024	Before Market	$-0.23	92.19%
08/09/2024	After Market	$-19.28	-489.60%
05/13/2024	After Market	$-0.18	53.85%
02/26/2024	After Market	$-0.86	47.56%
11/09/2023	After Market	$-1.83	-22.82%
08/10/2023	After Market	$-2.68	2.55%
05/08/2023	Before Market	$-3.25	-7.26%
03/13/2023	Before Market	$-0.56	34.88%
11/07/2022	Before Market	$-0.69	32.35%
08/08/2022	Before Market	$-1.22	15.28%
05/09/2022	Before Market	$-1.60	-7.38%
03/14/2022	Before Market	$-2.24	-16.67%
11/08/2021	Before Market	$-1.60	28.57%
08/09/2021	After Market	$-2.24	-7.69%
05/10/2021	After Market	$-2.24	-27.27%
03/15/2021	After Market	$-3.20	-33.33%
11/09/2020	Before Market	$-2.88	18.18%
08/10/2020	Before Market	$-7.36	-2.22%
05/12/2020	Before Market	$-9.60	4.76%
03/24/2020	After Market	$-91.52	-91.95%
11/08/2019	After Market	$-182.08	-30.80%
08/12/2019	Before Market	$-304	3.72%
05/13/2019	Before Market	$-412.80	-19.44%
03/18/2019	Before Market	$-1,952	-66.51%
11/09/2018	Before Market	$-1,824	5.39%
08/13/2018	Before Market	$-2,336	8.18%
05/11/2018	After Market	$-2,816	-25.71%
03/09/2018	After Market	$-2,176	12.26%
11/06/2017	After Market	$-2,464	-10.00%
08/11/2017	After Market	$-2,080	16.67%
05/12/2017	After Market	$-4,064	6.62%
03/03/2017	---	$-2.97	97.72%
11/10/2016	After Market	$-9,280	13.86%
08/05/2016	After Market	$-16,000	8.54%
05/09/2016	Before Market	$-23,680	-18.09%
03/04/2016	Before Market	$-22,720	-7.58%
11/09/2015	Before Market	$-23,040	-16.13%
08/07/2015	After Market	$-23,360	-12.31%
05/08/2015	After Market	$-22,720	-32.71%
03/03/2015	Before Market	$-26,560	-2.47%
11/07/2014	After Market	$-22,720	-2.90%
08/08/2014	---	$-19,520	-15.09%
05/13/2014	---	$-18,880	-68.57%
03/31/2014	---	$-23,680	-60.87%
11/13/2013	---	$-27,840	-35.94%
08/28/2013	---	$-190,772.90	---
05/29/2013	---	$-185,371.24	---
12/31/2012	---	$-310,484.25	---
09/30/2012	---	$-202,112.70	---
06/30/2012	---	$-358,673.27	---
03/31/2012	---	$-235,131.82	---

More About Tonix Pharmaceuticals Holding Corp

Website

https://www.tonixpharma.com

Country

USA

Full Time Employees

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for the management of fibromyalgia; and is being developed to prevent and treat acute stress reaction, posttraumatic stress disorder, Alzheimer's disease, alcohol use disorder, and multi-site pain associated with Long COVID. It also develops TNX-1300, a double-mutant cocaine esterase, which is in Phase 2 clinical trials for the treatment of cocaine intoxication; and TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, as well as for social anxiety disorder. In addition, the company develops TNX-1500, an Fc-modified humanized monoclonal antibody indicated to prevent organ transplant rejection, as well as to treat autoimmune conditions; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; TNX-801 that is in the pre-IND development stage for protection against smallpox and mpox; and TNX-1800, a live virus vaccine for SARS-CoV-2. Its rare disease portfolio consists of TNX-2900, an intranasal potentiated oxytocin to treat for Prader-Willi syndrome. The company has collaboration agreement with Bilthoven Biologicals to advance TNX-801 and Makana Therapeutics, Inc. to study TNX-1500 for human-compatible organs and cells for the treatment of organ failure. Tonix Pharmaceuticals Holding Corp. is headquartered in Chatham, New Jersey.

“Tonix Pharmaceuticals Holding Corp Earnings” Can Refer to the Tonix Pharmaceuticals Holding Corp Earnings Date

Some people say “Tonix Pharmaceuticals Holding Corp earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tonix Pharmaceuticals Holding Corp position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tonix Pharmaceuticals Holding Corp Stock on the Earnings Date

If you own Tonix Pharmaceuticals Holding Corp stock (TNXP) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tonix Pharmaceuticals Holding Corp might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tonix Pharmaceuticals Holding Corp shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tonix Pharmaceuticals Holding Corp Earnings

You can contact us any time if you would like to ask questions about Tonix Pharmaceuticals Holding Corp earnings or anything else related to the stock market.